Catharina
Catharina Ellerström, Vastra Frolunda SE
Patent application number | Description | Published |
---|---|---|
20090269830 | Culture System and Method for Propagation of Human Blastocyst-Derived Stem Cells - The present invention relates to a culture system for and a method for propagation of human blastocyst-derived stem cells (hBS cells) upon enzymatic dissociation into a single cell suspension. The culture system for propagation of human blastocyst-derived stem (hBS) cells comprises | 10-29-2009 |
20100129906 | Method for Obtaining Xeno-Free Hbs Cell line - A method for obtaining a stable xeno-free hBS cell line, xeno-free hBS cell lines obtained according to said method and use thereof. The method comprises the steps of: | 05-27-2010 |
Catharina Ellerström, Vastra Frolunda SE
Patent application number | Description | Published |
---|---|---|
20100129906 | Method for Obtaining Xeno-Free Hbs Cell line - A method for obtaining a stable xeno-free hBS cell line, xeno-free hBS cell lines obtained according to said method and use thereof. The method comprises the steps of: | 05-27-2010 |
Catharina Hippius, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20120094007 | METHOD FOR THE IMMOBILIZATION OF CATIONIC ACTIVE INGREDIENTS ON SURFACES - A method and composition for immobilizing an antimicrobial active ingredient on a surface of a substrate, in which the surface of the substrate is treated with a composition comprising | 04-19-2012 |
20130195793 | RADIATION-CURABLE ANTIMICROBIAL COATINGS - The present invention relates to radiation-curable antimicrobial coatings, to a process for preparation thereof, and to the use thereof. | 08-01-2013 |
20130196075 | RADIATION-CURABLE ANTIMICROBIAL COATINGS - The present invention relates to radiation-curable antimicrobial coatings, to a process for preparation thereof, and to the use thereof. | 08-01-2013 |
20130196079 | RADIATION-CURABLE ANTIMICROBIAL COATING COMPOSITION - The present invention relates to a radiation-curable antimicrobial coating composition, to a process for preparation thereof, and to the use thereof. | 08-01-2013 |
Catharina Houdijk, Rotterdam NL
Patent application number | Description | Published |
---|---|---|
20100047391 | REDUCED-SALT DAIRY PRODUCT WITH IMPROVED TASTE - The present invention relates to a method for preparing a dairy product with reduced sodium, wherein a yeast extract comprising at least 30% w/w 5′-ribonucleotides, on the basis of sodium chloride free dry matter, is added to a dairy composition used in the production of dairy product with reduced sodium. Preferably, a yeast extract is used wherein the total amount of 5′-GMP plus 5′-IMP is at least 15% w/w on the basis of sodium chloride free dry matter. The method of the invention may advantageously be used since off-tastes are masked and salt perception is enhanced. | 02-25-2010 |
Catharina Knieke, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20120220198 | METHOD OF PRODUCING PLATELETS COMPRISING A LAYERED MATERIAL - A method of producing from particles of a layered material platelets comprising the layered material, the method comprising the steps of: mixing the particles of the layered material in a liquid medium; and exposing said mixed-in particles to a mechanical grinding treatment, thereby exfoliating at least some of the particles of the layered material to produce platelets from the layered material. Moreover, a method of producing from particles of a layered material platelets comprising the layered material, wherein the particles are exposed to a mechanical grinding treatment using grinding media, the stress energy of the grinding media SE | 08-30-2012 |
Catharina Larsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20090035763 | Methods for Detecting Progression of Low Grade Cervical Dysplasia and for Detecting Adenocarcinomas - The invention provides methods for identifying conditions of low grade cervical dysplasia and assessing the progressive potential of individual lesions to develop into high grade cervical dysplasia and cervical squamous cell cancer as well as cervical adenocarcinoma. | 02-05-2009 |
20140005063 | METHOD FOR DETECTING RISK OF PROGRESSION OF LOW GRADE CERVICAL DYSPLASIA | 01-02-2014 |
Catharina Quitmann, Koln DE
Patent application number | Description | Published |
---|---|---|
20080219915 | Carbon black, method of producing carbon black, and device for implementing the method - The invention relates to a carbon black having an aggregate size distribution which has a (d | 09-11-2008 |
20120328881 | Carbon Black, Method of Producing Carbon Black and Device for Implementing the Method - The invention relates to a carbon black having an aggregate size distribution which has a (d | 12-27-2012 |
Catharina Svanborg, Malmo SE
Patent application number | Description | Published |
---|---|---|
20150216945 | PROPHYLACTIC AND NUTRACEUTICAL THERAPY - A biologically active complex comprising a polypeptide having the sequence of a naturally occurring protein or a variant thereof, wherein said polypeptide is at least partially unfolded as compared to the said naturally occurring protein for example as a result of a modification of at least one cysteine residue; or a peptide of up to 50 amino acids; and a fatty acid or lipid or a salt thereof, for use in prophylactic treatment of cancers, in particular of the gastrointestinal tract. Compositions that may comprise the complex and have use as nutraceuticals are obtainable from milk or milk fractions and form a further aspect of the invention. Methods of treatment in particular for the prevention of cancer form a further aspect of the invention. | 08-06-2015 |
Catharina Svanborg, Lund SE
Patent application number | Description | Published |
---|---|---|
20090036368 | Therapeutic Combination - A combination of component (i) which is HAMLET or a biologically active modification thereof, or a biologically active fragment of either of these, and component (ii) which is a histone deacetylase (HDAC) inhibitor. This combination shows synergistic effects in the treatment of for example proliferative diseases such as those which produce tumours. | 02-05-2009 |
20120028883 | COMPLEX AND PRODUCTION PROCESS - A method for preparing a biologically active complex, said method comprising a recombinant protein having the sequence of α-lactalbumin, such as human α-lactalbumin or a fragment thereof but which lacks intra-molecular disulfide bonds, and oleic acid, and process for preparing this are described and claimed. The recombinant protein suitably has cysteines found in the native protein changed to other amino acids, such as alanine. Improvements in recombinant expression, process rationalisation and yields of biologically active complexes, as well as the complexes obtained are also described and claimed. | 02-02-2012 |
20140051636 | BIOLOGICALLY ACTIVE COMPLEX AND ITS PREPARATION - A biologically active complex comprising either a polypeptide having the sequence of a variant of a naturally occurring protein, wherein said polypeptide is at least partially unfolded as compared to the said naturally occurring protein; or a peptide of up to 50 amino acids, for instance a fragment of the naturally occurring protein or a variant thereof; and a pharmaceutically acceptable salt of a fatty acid or lipid. The complexes of the invention demonstrate a novel mode of action, that gives rise to opportunities for the development of further active agents and screening methods. | 02-20-2014 |
Catharina Tennefors, Enebyberg SE
Patent application number | Description | Published |
---|---|---|
20150079225 | NUTRITIONAL COMPOSITION - A nutritional composition having a total energy content of 67 kcal/100 ml or lower and including: a protein content which is 1.25 g/100 ml or lower, an energy content from protein of 7.2-8.4% of the total energy content of the nutritional composition, an energy content from fat which is at least 49% or more of the total energy content of the nutritional composition, a medium chain fatty acid content comprising 8 to 10 carbons which is less than 3 wt % of total amount of fatty acids, a sialic acid content of 10-25 mg/100 ml, a cholesterol content of 5-10 mg/100 ml, and a sphingomyelin content of 9-15 mg/100 ml is disclosed. | 03-19-2015 |